Skip to main content
Clinical Trials/ACTRN12620001149954
ACTRN12620001149954
Not Yet Recruiting
N/A

Pilot study to embed electronic Patient Reported Outcome Measures and patient reported experience measures into routine care for patients with Stage III MELanoma (ePROMs-MEL)

The University of Sydney0 sites100 target enrollmentNovember 3, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Melanoma - Stage III
Sponsor
The University of Sydney
Enrollment
100
Status
Not Yet Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 3, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient key inclusion criteria:
  • Adults (over 18\)
  • Diagnosis of Stage III melanoma at least 3 months earlier
  • Under the care of melanoma clinicians at MIA or RPAH
  • Sufficient English and cognitive ability to comprehend study materials, provide informed consent and participate in this study
  • Clinician inclusion criteria:
  • Clinicians currently treating and managing patients with stage III melanoma at Sydney Melanoma Surgical Oncology clinics at MIA or RPAH.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials